| Followers | 48 |
| Posts | 4763 |
| Boards Moderated | 0 |
| Alias Born | 07/26/2010 |
Saturday, June 15, 2024 2:46:45 PM
https://www.hhs.gov/about/news/2024/06/13/barda-awards-500-million-project-nextgen-funding-vaccine-clinical-trials.html
Recent VXRT News
- Vaxart Provides Business Update and Reports Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/12/2026 08:05:00 PM
- Vaxart to Host Upcoming Conference Calls • GlobeNewswire Inc. • 03/03/2026 09:01:00 PM
- Vaxart to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026 • GlobeNewswire Inc. • 02/18/2026 01:00:00 PM
- Vaxart Publishes Positive Data for its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants • GlobeNewswire Inc. • 01/15/2026 01:00:00 PM
- Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026 • GlobeNewswire Inc. • 01/08/2026 09:01:00 PM
- Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/13/2025 09:05:00 PM
- Vaxart to Host Upcoming Conference Calls • GlobeNewswire Inc. • 11/07/2025 01:00:00 PM
- Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025 • GlobeNewswire Inc. • 10/20/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:00:20 PM
- Vaxart to Showcase its Norovirus and COVID-19 Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2025 • GlobeNewswire Inc. • 10/08/2025 12:00:00 PM
- Vaxart Announces Withdrawal of Reverse Stock Split Proposal • GlobeNewswire Inc. • 09/19/2025 12:00:00 PM
- Concerned Vaxart Stockholders Respond to Inadequate Governance Announcements • GlobeNewswire Inc. • 09/18/2025 01:00:00 PM
- Vaxart Appoints W. Mark Watson as Lead Independent Director • GlobeNewswire Inc. • 09/17/2025 08:05:01 PM
- Vaxart Reports Additional Phase 1 Data Supporting the Potential Efficacy of its Second-Generation Norovirus Oral Pill Vaccine Candidate • GlobeNewswire Inc. • 09/10/2025 08:54:58 PM
- Form PX14A6G - Notice of exempt solicitation submitted by non-management • Edgar (US Regulatory) • 09/10/2025 03:00:26 PM
- Concerned Vaxart Stockholders Condemn Board’s Decision to Adjourn Reverse Stock Split Vote at Special Meeting • GlobeNewswire Inc. • 09/10/2025 01:00:58 PM
- Vaxart Announces Adjournment of Special Meeting of Stockholders • GlobeNewswire Inc. • 09/08/2025 12:00:00 PM
- Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025 • GlobeNewswire Inc. • 09/03/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/02/2025 09:09:34 PM
- Vaxart Announces Retirement of Chairman Michael J. Finney, Ph.D. from the Board of Directors • GlobeNewswire Inc. • 09/02/2025 08:30:52 PM
- Form PX14A6G - Notice of exempt solicitation submitted by non-management • Edgar (US Regulatory) • 09/02/2025 06:09:22 PM
- Concerned Vaxart Stockholders Urge Fellow Stockholders to Vote “AGAINST” Reverse Stock Split and Demand Board Accountability • GlobeNewswire Inc. • 09/02/2025 01:00:00 PM
- Vaxart Granted Extension by Nasdaq to Regain Compliance • GlobeNewswire Inc. • 08/29/2025 12:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/21/2025 09:10:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2025 09:01:56 PM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
